CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 32 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $90,000 | -27.4% | 30,000 | 0.0% | 0.04% | -15.6% |
| Q2 2015 | $124,000 | -4.6% | 30,000 | 0.0% | 0.04% | -10.0% |
| Q1 2015 | $130,000 | +46.1% | 30,000 | 0.0% | 0.05% | +28.2% |
| Q4 2014 | $89,000 | -11.0% | 30,000 | 0.0% | 0.04% | -20.4% |
| Q3 2014 | $100,000 | +31.6% | 30,000 | 0.0% | 0.05% | +32.4% |
| Q2 2014 | $76,000 | +11.8% | 30,000 | 0.0% | 0.04% | -9.8% |
| Q1 2014 | $68,000 | +15.3% | 30,000 | 0.0% | 0.04% | +17.1% |
| Q4 2013 | $59,000 | – | 30,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 213,609 | $1,446,000 | 2.75% |
| GABLES CAPITAL MANAGEMENT INC. | 449,164 | $3,041,000 | 1.81% |
| Prairiewood Capital, LLC | 261,403 | $1,770,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 9,572,000 | $64,802,000 | 1.06% |
| Quantedge Capital Pte Ltd | 360,100 | $2,438,000 | 1.03% |
| SummerHaven Investment Management, LLC | 151,384 | $1,025,000 | 0.55% |
| GLOBEFLEX CAPITAL L P | 609,030 | $4,124,000 | 0.42% |
| EAM Global Investors LLC | 347,899 | $2,355,000 | 0.42% |
| Lanham O'Dell & Company, Inc. | 50,000 | $339,000 | 0.27% |
| EAM Investors, LLC | 239,071 | $1,619,000 | 0.27% |